Latest News about Pancreatic Cancer
Recent news which mentions Pancreatic Cancer
Cancer 2023: What’s Happening in the Combat Zone?
July 18, 2023
From Stock Gumshoe
From Benzinga
FDA Removes Clinical Hold On AIM ImmunoTech's Mid-Stage Ampligen Trial In Pancreatic Cancer
March 16, 2022
Tickers
AIM
From Benzinga
Amgen Posts Latest Batch of Lumakras Data In Pancreatic Cancer
February 15, 2022
Tickers
AMGN
From Benzinga
PharmaCyte Updates Status Of Investigational New Drug Application For Pancreatic Cancer Candidate
February 14, 2022
Tickers
PMCB
From Benzinga
Immix Biopharma's IMX-110 / Anti-PD-1 Combo Therapy Shows Extended Median Survival In Animal Studies
January 25, 2022
From Benzinga
ImmunityBio's Shares Jump On Encouraging Data From Pancreatic Cancer Immunotherapy Trial
January 19, 2022
Tickers
IBRX
From Benzinga
Gala to end Pancreatic Cancer Raises Over $1 Million
October 06, 2021
Tickers
AP
From Send2Press Newswire
Novocure To Test Its Tumor Treating Fields With Roche's Tecentriq In Pancreatic Cancer
September 14, 2021
From Benzinga
Why XOMA Stock Is Trading Higher Wednesday?
July 28, 2021
From Benzinga
Lantern Pharma Shares Moves Higher On Encouraging Data From Pancreatic Cancer Candidate In Animal Models
July 20, 2021
Tickers
LTRN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.